The headline is broadly defensible, but the qualifications matter. Effect sizes vary by population, the strongest claims rest on shorter trials, and credible voices push back on how it's typically framed.
A preclinical study in mice demonstrated that VEGF gene therapy effectively reversed biological aging and its hallmarks across multiple organs. This resulted in significant lifespan increases (48% in males, 39% in females), even with modest increases in VEGF levels (up to twice youthful levels).
Every Sunday: the week’s new conflicts and verdict changes — and nothing else.
Native comments, Twitter mentions, and Reddit threads about this claim — surfaced together so the conversation isn't fragmented across platforms.
Bookmarking — the dossier-vs-overview split is the right call. Most of the time I want overview; sometimes I want receipts.
Would love a "what would change this verdict" RSS feed. Sign me up if it exists.
A preclinical study indicated that VEGF gene therapy can reverse biological aging in multiple organs in mice, as well as reset several hallmarks of aging, including inflammation, declining mitochondrial function, and blood vessel senescence. The improvements resulted in 48% and 39% increases in lifespan in male and female mice, respectively.